Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.4900
- TODAY'S CHANGE (%)0.0800 (0.2816%)
- Bid / Lots28.3900/ 1
- Ask / Lots29.0000/ 1
- Open / Previous Close28.4100 / 28.4100
- Day Range
- 52 Week Range
- Volume1,860,971
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 13304 | 28.47 |
| 09:34 ET | 2919 | 28.41 |
| 09:36 ET | 3066 | 28.39 |
| 09:38 ET | 3150 | 28.43 |
| 09:39 ET | 4303 | 28.47 |
| 09:41 ET | 3151 | 28.47 |
| 09:43 ET | 7636 | 28.6 |
| 09:45 ET | 104380 | 28.62 |
| 09:48 ET | 3550 | 28.66 |
| 09:50 ET | 2010 | 28.61 |
| 09:52 ET | 5744 | 28.6655 |
| 09:54 ET | 19322 | 28.57 |
| 09:56 ET | 97689 | 28.57 |
| 09:57 ET | 22019 | 28.495 |
| 09:59 ET | 15927 | 28.56 |
| 10:01 ET | 56792 | 28.52 |
| 10:03 ET | 2800 | 28.525 |
| 10:06 ET | 6500 | 28.48 |
| 10:08 ET | 6405 | 28.545 |
| 10:10 ET | 8076 | 28.57 |
| 10:12 ET | 3800 | 28.61 |
| 10:14 ET | 2800 | 28.65 |
| 10:15 ET | 4490 | 28.709 |
| 10:17 ET | 1383 | 28.72 |
| 10:19 ET | 3702 | 28.72 |
| 10:21 ET | 3387 | 28.6471 |
| 10:24 ET | 3400 | 28.655 |
| 10:26 ET | 1400 | 28.66 |
| 10:28 ET | 773 | 28.66 |
| 10:30 ET | 4855 | 28.675 |
| 10:32 ET | 1400 | 28.655 |
| 10:33 ET | 5650 | 28.67 |
| 10:35 ET | 1999 | 28.67 |
| 10:37 ET | 2741 | 28.68 |
| 10:39 ET | 2293 | 28.67 |
| 10:42 ET | 2091 | 28.64 |
| 10:44 ET | 3580 | 28.595 |
| 10:46 ET | 2313 | 28.63 |
| 10:48 ET | 1900 | 28.59 |
| 10:50 ET | 8144 | 28.58 |
| 10:51 ET | 700 | 28.595 |
| 10:53 ET | 2400 | 28.58 |
| 10:55 ET | 5441 | 28.54 |
| 10:57 ET | 4526 | 28.555 |
| 11:00 ET | 5078 | 28.585 |
| 11:02 ET | 3088 | 28.58 |
| 11:04 ET | 4539 | 28.57 |
| 11:06 ET | 10403 | 28.55 |
| 11:08 ET | 31203 | 28.5 |
| 11:09 ET | 30391 | 28.5 |
| 11:11 ET | 13037 | 28.49 |
| 11:13 ET | 10151 | 28.47 |
| 11:15 ET | 6579 | 28.46 |
| 11:18 ET | 4793 | 28.46 |
| 11:20 ET | 6832 | 28.4499 |
| 11:22 ET | 3748 | 28.43 |
| 11:24 ET | 43812 | 28.475 |
| 11:26 ET | 3127 | 28.485 |
| 11:27 ET | 3173 | 28.49 |
| 11:29 ET | 51846 | 28.465 |
| 11:31 ET | 4599 | 28.47 |
| 11:33 ET | 2452 | 28.47 |
| 11:36 ET | 2000 | 28.475 |
| 11:38 ET | 3907 | 28.475 |
| 11:40 ET | 3341 | 28.465 |
| 11:42 ET | 1579 | 28.475 |
| 11:44 ET | 1704 | 28.475 |
| 11:45 ET | 1932 | 28.465 |
| 11:47 ET | 3484 | 28.4 |
| 11:49 ET | 1468 | 28.39 |
| 11:51 ET | 1380 | 28.405 |
| 11:54 ET | 1675 | 28.42 |
| 11:56 ET | 3110 | 28.41 |
| 11:58 ET | 250 | 28.4 |
| 12:02 ET | 500 | 28.405 |
| 12:03 ET | 4208 | 28.38 |
| 12:05 ET | 1400 | 28.37 |
| 12:07 ET | 3392 | 28.375 |
| 12:12 ET | 1330 | 28.385 |
| 12:14 ET | 6854 | 28.42 |
| 12:18 ET | 1603 | 28.415 |
| 12:20 ET | 3783 | 28.385 |
| 12:21 ET | 1925 | 28.41 |
| 12:23 ET | 900 | 28.41 |
| 12:25 ET | 700 | 28.41 |
| 12:27 ET | 400 | 28.4101 |
| 12:30 ET | 2019 | 28.42 |
| 12:32 ET | 4738 | 28.46 |
| 12:34 ET | 2999 | 28.445 |
| 12:36 ET | 650 | 28.45 |
| 12:38 ET | 5649 | 28.44 |
| 12:39 ET | 4867 | 28.415 |
| 12:41 ET | 1200 | 28.42 |
| 12:43 ET | 4137 | 28.4 |
| 12:45 ET | 6177 | 28.425 |
| 12:48 ET | 5645 | 28.43 |
| 12:50 ET | 1756 | 28.445 |
| 12:52 ET | 3392 | 28.44 |
| 12:54 ET | 1421 | 28.44 |
| 12:56 ET | 800 | 28.44 |
| 12:57 ET | 600 | 28.425 |
| 12:59 ET | 600 | 28.425 |
| 01:01 ET | 3186 | 28.405 |
| 01:03 ET | 5661 | 28.425 |
| 01:06 ET | 3881 | 28.43 |
| 01:08 ET | 2300 | 28.425 |
| 01:10 ET | 800 | 28.425 |
| 01:12 ET | 8868 | 28.435 |
| 01:14 ET | 1666 | 28.435 |
| 01:15 ET | 3542 | 28.425 |
| 01:17 ET | 4417 | 28.435 |
| 01:19 ET | 2192 | 28.445 |
| 01:21 ET | 1732 | 28.445 |
| 01:24 ET | 1200 | 28.455 |
| 01:26 ET | 6004 | 28.46 |
| 01:28 ET | 2997 | 28.46 |
| 01:30 ET | 1081 | 28.455 |
| 01:32 ET | 669 | 28.455 |
| 01:33 ET | 2305 | 28.445 |
| 01:35 ET | 1581 | 28.4448 |
| 01:39 ET | 2431 | 28.47 |
| 01:42 ET | 1535 | 28.48 |
| 01:44 ET | 18941 | 28.48 |
| 01:46 ET | 1718 | 28.49 |
| 01:48 ET | 1577 | 28.485 |
| 01:50 ET | 1677 | 28.49 |
| 01:51 ET | 300 | 28.5 |
| 01:53 ET | 2853 | 28.4889 |
| 01:57 ET | 2582 | 28.49 |
| 02:00 ET | 200 | 28.49 |
| 02:02 ET | 1347 | 28.49 |
| 02:04 ET | 1400 | 28.48 |
| 02:06 ET | 983 | 28.465 |
| 02:08 ET | 1732 | 28.485 |
| 02:09 ET | 3652 | 28.475 |
| 02:13 ET | 1245 | 28.495 |
| 02:15 ET | 1342 | 28.485 |
| 02:18 ET | 1138 | 28.49 |
| 02:20 ET | 2141 | 28.4993 |
| 02:22 ET | 3290 | 28.49 |
| 02:24 ET | 1601 | 28.495 |
| 02:26 ET | 3310 | 28.515 |
| 02:27 ET | 2410 | 28.52 |
| 02:29 ET | 600 | 28.52 |
| 02:31 ET | 3457 | 28.525 |
| 02:33 ET | 523 | 28.525 |
| 02:36 ET | 400 | 28.53 |
| 02:38 ET | 2274 | 28.52 |
| 02:40 ET | 1822 | 28.52 |
| 02:42 ET | 457 | 28.515 |
| 02:44 ET | 2936 | 28.5 |
| 02:45 ET | 1542 | 28.505 |
| 02:47 ET | 3411 | 28.48 |
| 02:49 ET | 787 | 28.485 |
| 02:51 ET | 2532 | 28.495 |
| 02:54 ET | 990 | 28.49 |
| 02:56 ET | 1700 | 28.4762 |
| 02:58 ET | 468 | 28.475 |
| 03:00 ET | 723 | 28.475 |
| 03:02 ET | 2691 | 28.475 |
| 03:03 ET | 4898 | 28.48 |
| 03:05 ET | 383 | 28.485 |
| 03:07 ET | 928 | 28.485 |
| 03:09 ET | 532 | 28.47 |
| 03:12 ET | 6460 | 28.455 |
| 03:14 ET | 4384 | 28.4594 |
| 03:16 ET | 4138 | 28.43 |
| 03:18 ET | 344 | 28.435 |
| 03:20 ET | 241 | 28.435 |
| 03:21 ET | 1811 | 28.435 |
| 03:23 ET | 3594 | 28.42 |
| 03:25 ET | 6588 | 28.425 |
| 03:27 ET | 6179 | 28.43 |
| 03:30 ET | 1567 | 28.435 |
| 03:32 ET | 979 | 28.435 |
| 03:34 ET | 1797 | 28.42 |
| 03:36 ET | 1183 | 28.425 |
| 03:38 ET | 966 | 28.42 |
| 03:39 ET | 6473 | 28.445 |
| 03:41 ET | 4010 | 28.455 |
| 03:43 ET | 3551 | 28.47 |
| 03:45 ET | 7565 | 28.465 |
| 03:48 ET | 5461 | 28.445 |
| 03:50 ET | 4508 | 28.455 |
| 03:52 ET | 6287 | 28.45 |
| 03:54 ET | 13536 | 28.445 |
| 03:56 ET | 51902 | 28.485 |
| 03:57 ET | 26823 | 28.475 |
| 03:59 ET | 277424 | 28.49 |
Apr 19, 2024
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024, from 8:15AM ET on Friday Apr 19, 2024 by Dow Jones
8:15AM ET on Friday Apr 19, 2024 by Dow Jones
Apr 17, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow JonesPress Release: Royalty Pharma Declares Second Quarter 2024 Dividend, from 8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:15AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 12, 2024
DJ Royalty Pharma Is Maintained at Buy by B of A Securities, from 8:11AM ET on Friday Apr 12, 2024 by Dow Jones
8:11AM ET on Friday Apr 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 17.0B | 11.2x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -21.3x | --- |
Catalent Inc | 10.2B | -7.9x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.7x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Roivant Sciences Ltd | 9.2B | 2.3x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.0B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.95% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $2.54 |
Book Value | $14.61 |
P/E Ratio | 11.2x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 10.0x |
Operating Margin | 63.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
